Cartesian Therapeutics

Clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases.

[Cartesian Therapeutics @CartesianTX]

We are proud to have participated in the MGFA Scientific Session at #AANEM. To learn more about the retreatment data we presented: https://t.co/sNsLVKyRlT

We look forward to topline results from our Phase 3 AURORA trial in 1Q27.

#CellTherapy #Autoimmunity #RareDisease

[Cartesian Therapeutics @CartesianTX]

Meet us during the MGFA Scientific Session at #AANEM in Orlando and attend our presentation of Descartes-08 retreatment data following a full treatment course in the Phase 2 portion of the study supporting our ongoing Phase 3 AURORA trial in #MG. https://t.co/QzIoO3aTS6

[Cartesian Therapeutics @CartesianTX]

Tune in tomorrow at 1:30 pm ET to hear our fireside chat at the H.C. Wainwright & Co. 28th Annual Global Investment Conference. Listen to the webcast here: https://t.co/2klsy00ize

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Tune in tomorrow at 3:55 pm ET to hear our fireside chat at the Cantor Global Healthcare Conference. Listen to the webcast here: https://t.co/SD6scioH2V

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Today, we reported second quarter 2026 financial results and provided a business update. Read the full press release here: https://t.co/P3hD4Vs835

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

We’re excited to announce a strategic licensing agreement with WestGene Biopharma to advance the development of novel in vivo chimeric antigen receptor T-cell (CAR-T) therapies in #autoimmune diseases.
Read more: https://t.co/tcJzpP9SZi

[Cartesian Therapeutics @CartesianTX]

We are excited to announce we entered into an agreement with K2 HealthVentures to provide a credit facility of up to $150 million, extending cash runway into 2028. We also announced progress and updated timelines for all ongoing trials.

Read more: https://t.co/OgfF2X6Aiw

[Cartesian Therapeutics @CartesianTX]

Tune in tomorrow at 3:00 pm ET to hear our fireside chat at the H.C. Wainwright 4th Annual BioConnect Nasdaq Investor Conference. Listen to the webcast here: https://t.co/MtLWizyjYZ

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Our team is on the ground at the @ASGCTherapy 2026 Annual Meeting kicking off tomorrow. Come see our posters to hear more about our work in #myastheniagravis.

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Today we reported first quarter 2026 financial results and provided a business update. Full press release: https://t.co/EnpeynN83R

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

We attended the @AANmember 2026 Annual Meeting this week! We had a lovely time connecting with researchers and doctors from around the world on new and exciting potential therapies for #MG. Learn more about our Ph3 AURORA trial: https://t.co/dGdiUbnM73
#CellTherapy #Autoimmune

[Cartesian Therapeutics @CartesianTX]

Our team is on the ground at the @AANmember 2026 Annual Meeting kicking off tomorrow. Come see our poster to hear more about our work in #myastheniagravis.

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Our team is on the ground at the @AANmember 2026 Annual Meeting kicking off tomorrow. Come see our poster to hear more about our work in #myastheniagravis.

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Our team attended the @MyastheniaOrg National Patient Conference this week! It was great to meet and connect with patients, families, advocates and #MG experts throughout the event. To learn more about our Phase 3 AURORA trial: https://t.co/NT0uoYZf3n

[Cartesian Therapeutics @CartesianTX]

Tune in tomorrow at 9:30 am ET to hear our fireside chat at the Needham Virtual Healthcare Conference. Listen to the webcast here: https://t.co/mThEaaPfc3

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Tune in tomorrow at 9:30 am ET to hear our fireside chat at the Needham Virtual Healthcare Conference. Listen to the webcast here: https://t.co/mThEaaPfc3

#celltherapy #autoimmunity

[Cartesian Therapeutics @CartesianTX]

Last month we participated in Cantor's #RareDiseaseDay webinar series discussing #Myositis, a rare set of pathogenic autoantibody-driven diseases characterized by inflammation and muscle weakness that impacts ~80,000 people in the U.S. Learn more here: https://t.co/kKTfTI5WRi

[Cartesian Therapeutics @CartesianTX]

Our team is on the ground at the International Myositis Society 6th Global Conference on Myositis kicking off today. Come see our posters and hear more about our work in #Myositis.

View our posters: https://t.co/DZEkSGUKrl
Learn more: https://t.co/kKTfTI5WRi
#RareDisease

[Cartesian Therapeutics @CartesianTX]

We are at the @MDAorg congress this week. Come see our poster to hear more about our work in #myastheniagravis which was recently published in Nature Medicine! This will be our first time presenting this at a medical meeting. See our publications here: https://t.co/9WaYLlTrhb

[Cartesian Therapeutics @CartesianTX]

Today we reported full year 2025 financial results and provided a business update. Full press release: https://t.co/ycucVuQ7qE

#celltherapy #autoimmunity